dilazep

This page covers all dilazep drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Equilibrative nucleoside transporter 1, Sodium channel alpha subunits; brain (Types I, II, III), Equilibrative nucleoside transporter 2.

Targets

Equilibrative nucleoside transporter 1, Sodium channel alpha subunits; brain (Types I, II, III), Equilibrative nucleoside transporter 2

Phase 2 pipeline (1)

• DILAZEP · Other
  DILAZEP works by blocking the ENT1 transporter, which regulates the flow of certain molecules into cells.

Patent intelligence

• dilazep patent landscape — aggregated cliff calendar, attackable patents, originator estates